Cancer Research
November 11, 2025
For millions of women around the world, a "clear" mammogram result can be a dangerous false reassurance. The hard truth is that mammograms miss up to 40% of breast cancers in women with dense breast tissue. This isn't a rare issue—it's a global clinical blind spot that turns early, treatable cancer into a late-stage crisis.
October 31, 2025
CDC, the U.S. Food and Drug Administration (FDA), state and local health departments, and other clinical and public health partners are continuing to monitor e-cigarette, or vaping, product use-associated lung injury (EVALI).
October 22, 2025
The New Frontier in Cancer Therapy Cancer therapy is evolving — again.Recent clinical data show that Tislelizumab, a humanized anti–PD-1 monoclonal antibody, combined with chemotherapy, extends […]
October 2, 2025
October is Breast Cancer Awareness Month, and most conversations focus on genetics, mammograms, and treatment advances. But there’s a blind spot: toxicology. Everyday exposures—from endocrine-disrupting chemicals in plastics to drug-induced toxicities during treatment—can shape both breast cancer risk and recovery. If you’re a clinician, researcher, or public health leader, here’s the clear idea: you can’t talk about breast cancer prevention or survivorship without talking about toxicology.
